OnKure Therapeutics, Inc. OKUR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$15.16M-12.2% | -$13.5M+8.1% | -$14.7M+4.5% | -$15.39M+3.4% | -$15.93M+8.7% | ||
| $104K0.0% | $104K-3.7% | $108K-7.7% | $117K-0.8% | $118K+1.7% | ||
| $2.78M-7.9% | $3.02M+2.0% | $2.96M+1.8% | $2.91M+5.9% | $2.75M+8.4% | ||
| -$12.94M-12.4% | -$11.51M+11.7% | -$13.04M+1.8% | -$13.27M+5.2% | -$14.01M+40.0% | ||
| $5K-44.4% | $9K+50.0% | $6K-53.8% | $13K-27.8% | $18K+20.0% | ||
| -$5K+44.4% | -$9K-50.0% | -$6K+53.8% | -$13K+27.8% | -$18K-100% | ||
| —— | —— | —— | —— | —— | ||
| $146M+60,733% | $240K— | —— | —— | -$77K-100% | ||
| $133.06M+1,279% | -$11.28M+13.5% | -$13.04M+1.8% | -$13.29M+5.8% | -$14.1M-114% | ||
| -$12.94M-12.3% | -$11.52M+11.7% | -$13.04M+1.8% | -$13.29M+5.2% | -$14.02M+40.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OnKure Therapeutics, Inc. generate?
- OnKure Therapeutics, Inc. (OKUR) generated -$50.8M in operating cash flow over the trailing twelve months.
- What is OnKure Therapeutics, Inc.'s free cash flow?
- After $33.0K of capital expenditures, OnKure Therapeutics, Inc.'s free cash flow was -$50.8M over the trailing twelve months, up 6.9% year over year.
- Where does OnKure Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.